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Abstract
Analysis of the occurrence of adverse events, and in particular of solicited symptoms,
following vaccination is often needed for the safety and benet-risk evaluation of any
candidate vaccine, and typically involves taking repeated measurements. In this article, it
is shown that Linear Categorical Marginal Models are well-suited to take the dependencies
in the data arising from the repeated measurements into account and provide detailed
and useful information for comparing safety proles of dierent products while remaining
relatively easy to interpret. Linear Categorical Marginal Models are presented and applied
to a Phase III clinical trial of a candidate meningoccocal pediatric vaccine.
keywords : Marginal models, repeated categorical data, vaccine development, safety.
1 Introduction
When developing new vaccines, it is necessary to show that new candidates have an acceptable
safety prole. Typically, the clinical safety evaluation of the vaccine is performed regarding
two specic aspects. First, the occurrence of a certain number of local or general symptoms
is checked proactively via diary cards recording the occurrence or absence of the symptom
during a certain number of days after the injection. These symptoms are usually called
solicited symptoms. For ease of recording a standard intensity scale is often used and contains
a certain number of possible intensity of the symptom, typically between 1 and 3 (see, for
example Table 1). Subjects are then asked to ll in the maximum daily intensity of each
reported solicited symptom during the entire solicited symptom follow-up period in the diary
card. We will consider here a 4-day follow-up period, the day of vaccination being denoted
as day 1.
In parallel to this solicited symptoms collection, the subject is asked to record any occurrence
of adverse event experience that could also occur post vaccination. As there is no pre-
specication of the type or medical classication of the symptoms for which information is
requested, these symptoms are usually called unsolicited symptoms.
In order to avoid dierent types of biases, solicited and unsolicited symptoms occurring
after the vaccination by the candidate vaccine (hereafter denoted as active group) are often
compared to the ones obtained after injection of a licensed vaccine (control group) observed
in the same experimental conditions.
This paper will focus on the analysis of solicited symptoms. As the outcomes of these symp-
toms are often collected as categorical variables, the analysis methods presented below will
specically take this aspect into account. Several ways for comparing the active and the
control groups will be presented and compared. First, the data along with standard methods
1
2Table 1: Denition of solicited adverse events intensities
Adverse Event Intensity Description
Pain 0 Absent
1 Minor reaction to touch
2 Cries/protests on touch
3 Cries when limb is moved/spontaneously painful
Redness 0 Absent
1 >0 to  10 mm
2 >10 to  30 mm
3 >30 mm
Irritability 0 Behavior as usual
1 Crying more than usual/no eect on normal activities
2 Crying more than usual/interferes with normal activities
3 Crying that cannot be comforted/interferes with normal
activities
at injection site.
presenting results for each day or overall will be introduced in Section 2, where the diculties
caused by the fact that we have dependencies in the data due to the repeated measurements
are outlined. To overcome these diculties, Linear Categorical Marginal Models (LCMMs),
which take these dependencies into account, will be proposed in Section 3. For the ease of
presentation, we will rst consider the analysis of the occurrence of any event regardless of
the intensity. Analyses taking into account the several intensities will only be dealt with in
Section 4. Results from simulated data evaluating the Linear Categorical Marginal Models
will be presented in Section 5. Finally, the advantages and drawbacks of Linear Categorical
Marginal Models obtained via a Maximum Likelihood estimation procedure will be discussed.
2 Case Study
The data analyzed in this manuscript is coming from a Phase III trial of a meningococcal
vaccine in children. For condentiality reasons only partial data of the trial are used to
illustrate our methods. In this study, children at age 12 to 15 months are randomly assigned
3:1 to 2 groups to be either vaccinated by the candidate vaccine or by a control. The candidate
vaccine should oer a broader protection to meningococcal infection, so the safety question
of interest is whether the safety prole of the vaccine is or is not worse than the control. The
information collected for the solicited local symptoms is summarized in the rst six columns
of Table 2. The vaccine is injected in the upper left thigh at day 1, and the parents of the
subjects are asked to ll in diary cards indicating whether or not the vaccinee experienced
either pain, redness, or irritability during the follow-up period of 4 days.
Below, we rst present some simple classical analyses involving Bonferroni-Holm corrections,
and highlight the diculties that arise due to the dependencies in the data as the measure-
ments on the dierent days involve the same subjects.
In order to have an indication of the dierence between the 2 groups, it is possible, for each
day to test whether the dierence in occurrence of the symptom is statistically signicant.
For example, Table 2 presents results from exact tests comparing the percentage of subjects
3Table 2: Dierences between groups in percentage of subjects reporting a specied solicited
local symptom during the 4-day post vaccination period.
Control Active Control - Active
(N=499) (N=1381) 95%CI p-value
Symptom Day n % n % % LL UL Raw B-H
Pain 1 333 66.7 929 67.3 -0.54 -5.80 4.39 0.824 1.000
2 252 50.5 613 44.4 6.11 1.00 11.41 0.021 0.084
3 116 23.2 264 19.1 4.13 -0.31 9.05 0.051 0.154
4 49 9.8 102 7.4 2.43 -0.80 6.35 0.102 0.204
Any 366 73.3 1025 74.2 -0.87 -5.98 3.80 0.721 {
Redness 1 310 62.1 797 57.7 4.41 -0.70 9.59 0.090 0.090
2 312 62.5 769 55.7 6.84 1.73 12.01 0.008 0.025
3 214 42.9 504 36.5 6.39 1.30 11.69 0.013 0.027
4 115 23.0 236 17.1 5.96 1.57 10.83 0.004 0.016
Any 382 76.6 979 70.9 5.66 0.83 10.67 0.017 {
Irritability 1 221 44.3 570 41.3 3.01 -2.10 8.32 0.245 0.703
2 218 43.7 587 42.5 1.18 -3.93 6.50 0.675 0.703
3 164 32.9 413 29.9 2.96 -1.94 8.20 0.234 0.703
4 115 23.0 246 17.8 5.23 0.83 10.12 0.012 0.047
Any 279 55.9 763 55.2 0.66 -4.46 5.85 0.834 {
Note: Since the measurements on the four days and of the three symptoms are done on the same
subjects, the dierences between groups are correlated but this specic correlation is not taken into
account here.
4with the solicited symptom (p-values correspond to Fisher's exact test p-values). As sev-
eral comparisons have been made, the p-values have been adjusted by symptom using the
Bonferroni-Holm method, denoted the B-H p-value (see Holm, 1979). Note that, because
within each subject the several p-values are likely to be correlated, this correction method
may not be optimal. However, as it does not require any assumptions (model or distribu-
tion related) and its family-wise error rate does not exceed 5%, this test could be used here
although it may be too conservative which may be problematic as it might mask a possible
dierence. For more complex settings with multiple doses or when several symptoms have to
be considered simultaneously, other multiplicity correction methods such as the double false
discovery rate (Mehrotra & Heyse, 2004) could be considered. Considering the unadjusted
tests (regardless of intensity, i.e., the `All' rows in Table 3), we would nd statistically signif-
icant dierences in the occurrence of pain (day 2), redness (days 2, 3 and 4) and irritability
(day 4). However, when taking into account the multiplicity of the tests within a symptom
via the B-H method, no statistically signicant dierence would be found for pain. Hence,
as this example illustrates, it may not be uncommon to be in a situation in which several
tests are signicant when not adjusting for multiplicity, but no or fewer tests are signicant
if adjusted with an adjustment method that does not use all information in the data, leav-
ing the user in doubt of which conclusion to draw especially as the B-H method is likely
to overcorrect for multiplicity here. The problem magnies if the intensities of the solicited
symptoms experienced have to be taken into account such as in Table 3. There, as the B-H
correction is applied per symptom, no B-H p-value is signicant anymore for irritability, and
only one out of the 6 signicant p-values for redness remain signicant when corrected for
multiplicity.
An alternative analysis disregards intensity and only considers whether or not the symptom
occurred on any of the four days. Here, a statistically signicant dierence would only be
observed for redness (see Table 2). However, although this method is perfectly valid and
circumvents the problem of repeated measures, substantial information may be lost. Indeed,
it is possible that certain eects are visible during certain days but not during others, which
could be the case for pain and irritability.
3 Linear Categorical Marginal Models
Table 2 shows the percentage dierences of occurrence of various solicited symptoms between
control and active groups are reported. In this section, we discuss some models for these
data, using which we can answer various questions of interest, such as whether or not there
are statistically signicant dierences between the responses on the four days. Since we have
repeated measurements, i.e., measurements on dierent days involving the same subjects,
dependencies arise which need to be taken into account. This can be done naturally using
marginal modeling techniques.
3.1 Denition of the marginal proportions
Let the variable G denote the group a respondent is in (G = 1 for the active group and G = 2
for the control group), let S denote whether or not the solicited symptom occurred (S = 1
if the symptom occurred, S = 2 if it didn't), and let T denote the time after intervention in
days (T = 1; 2; 3; 4). The proportion of respondents who are in group G = g with solicited
symptom S = s given time T = t is denoted by Ss
G
g
jT
t . We should note that these 
S
s
G
g
jT
t
are not proportions of an ordinary contingency table, but marginal proportions of a larger
contingency table. Since for each solicited symptom, each subject in each group has four
5Table 3: Dierences between groups in percentage of subjects reporting a specied solicited
local symptom during the 4-day post vaccination period.
Control Active Control - Active
(N=499) (N=1381) 95% CI p-value
Symptoms Intensity n % n % % LL UL Raw B-H
Day 1
Pain All 333 66.7 929 67.3 -0.54 -5.8 4.39 0.824 1.000
2 or 3 143 28.7 300 21.7 6.93 2.25 12.02 0.002 0.021
3 33 6.6 31 2.2 4.37 1.83 7.63 <0.001 0.001
Redness All 310 62.1 797 57.7 4.41 -0.7 9.59 0.090 0.538
2 or 3 39 7.8 80 5.8 2.02 -0.93 5.69 0.133 0.626
3 2 0.4 18 1.3 -0.9 -3.22 1 0.125 0.626
Irritability All 221 44.3 570 41.3 3.01 -2.1 8.32 0.25 1.000
2 or 3 31 6.2 88 6.4 -0.16 -3.86 3.17 1.000 1.000
3 4 0.8 19 1.4 -0.57 -3.07 1.49 0.476 1.000
Day 2
Pain All 252 50.5 613 44.4 6.11 1 11.41 0.021 0.169
2 or 3 93 18.6 153 11.1 7.56 3.55 12.11 <0.001 0.001
3 14 2.8 14 1 1.79 -0.03 4.42 0.008 0.075
Redness All 312 62.5 769 55.7 6.84 1.73 12.01 0.008 0.091
2 or 3 91 18.2 189 13.7 4.55 0.48 9.17 0.016 0.125
3 16 3.2 42 3 0.17 -2.01 3.13 0.880 1.000
Irritability All 218 43.7 587 42.5 1.18 -3.93 6.5 0.673 1.000
2 or 3 67 13.4 149 10.8 2.64 -1.03 6.93 0.120 0.958
3 15 3 34 2.5 0.54 -1.53 3.41 0.514 1.000
Day 3
Pain All 116 23.2 264 19.1 4.13 -0.31 9.05 0.051 0.358
2 or 3 25 5 43 3.1 1.9 -0.53 5.08 0.068 0.407
3 2 0.4 7 0.5 -0.11 -2.22 1.74 1.000 1.000
Redness All 214 42.9 504 36.5 6.39 1.3 11.69 0.013 0.121
2 or 3 54 10.8 102 7.4 3.44 0.11 7.42 0.023 0.159
3 11 2.2 19 1.4 0.83 -0.95 3.43 0.214 0.641
Irritability All 164 32.9 413 29.9 2.96 -1.94 8.2 0.234 1.000
2 or 3 54 10.8 115 8.3 2.49 -0.88 6.52 0.101 0.905
3 14 2.8 21 1.5 1.28 -0.62 4 0.081 0.813
Day 4
Pain All 49 9.8 102 7.4 2.43 -0.8 6.35 0.102 0.509
2 or 3 10 2 14 1 0.99 -0.68 3.49 0.104 0.509
3 2 0.4 4 0.3 0.11 -0.98 2.08 0.659 1.000
Redness All 115 23 236 17.1 5.96 1.57 10.83 0.004 0.047
2 or 3 23 4.6 31 2.2 2.36 0.09 5.41 0.011 0.114
3 0 0 2 0.1 -0.14 -1.49 1.42 1.000 1.000
Irritability All 115 23 246 17.8 5.23 0.83 10.12 0.012 0.142
2 or 3 38 7.6 69 5 2.62 -0.26 6.21 0.042 0.459
3 4 0.8 8 0.6 0.22 -1.09 2.39 0.530 1.000
6measurements taken on the four days, the full contingency table for a solicited symptom
involves ve variables: G, the group the subject is in, S1, whether a solicited symptom
occurred on day 1, S2, whether a solicited symptom occurred on day 2, and so on. Denote by
Gg
S1
s1
S2
s2
S3
s3
S4
s4 the proportion of subjects in group G = g with symptom Si = si on day i (Si = 1
if the symptom occurred on day i and Si = 0 if the symptom did not occur on day i). Then,
with a `+' in the subscript denoting summation over that subscript,
Ss
G
g
jT
1 = 
G
g
S1
s
S2
+
S3
+
S4
+
Ss
G
g
jT
2 = 
G
g
S1
+
S2
s
S3
+
S4
+
Ss
G
g
jT
3 = 
G
g
S1
+
S2
+
S3
s
S4
+
Ss
G
g
jT
4 = 
G
g
S1
+
S2
+
S3
+
S4
s
That is, the Ss
G
g
jT
t are marginal proportions. We next discuss some models for these marginal
proportions.
3.2 Modeling the dierences in marginal proportions
Various questions can be asked about the data in Table 2 concerning changes in the response
patterns over the four days. The conditional probability that S = s given G = g and T = t
is denoted
Ss
jG
g
T
t =
Ss
G
g
jT
t
Ss
jT
t
The dierences in the marginal proportions for active and control group at time t are denoted
Tt = 
S
1
jG
1
T
t   S1 jG2 Tt
and can be estimated by dierent models. The saturated model, later called varying dier-
ence model, which does not impose any restrictions but whose parameters can be useful for
interpretation, is denoted by
Tt = + t for all t, (1)
for some unknown parameters  and t. Here, the  parameters are not identied but can be
identied by imposing a restriction such as
P
t t = 0 (cf. eect coding in ANOVA). Various
other models of interest are obtained by imposing restrictions on the  and  parameters.
The most parsimonious model asserting no dierences between active and control is obtained
by setting  = 0 and t = 0, i.e.,
Tt = 0 for all t. (2)
We will refer to this model as the no dierence model. The presence of a dierence but one
which does not change over time is
Tt =  for all t. (3)
We will refer to this model as the constant dierence model. Finally, a dierence between
active and control which changes linearly over time is formulated as
Tt = + :t for all t. (4)
We will refer to this model as the linear dierence model.
Since the Ss
jG
g
T
t are marginal proportions, and the aforementioned models are linear in these,
we will call them Linear Categorical Marginal Models (LCMMs)
73.3 Fitting Linear Categorical Marginal Models
Before we describe the tting procedure, we rst formulate the model in matrix notation.
Denote the vector of proportions for the full table, i.e., the Gg
S1
s1
S2
s2
S3
s3
S4
s4 , by . The vector of
marginal proportions of interest are a linear combination of the elements of  and can thus
be written as
M
whereM is an appropriate matrix of zeroes and ones (for more details see Bergsma, Croon, &
Hagenaars, 2009). Let  be the vector of Tt . We can use the generalized exp-log notation of
Kritzer (1977) and Bergsma et al. (2009) to represent , which we denote (M) to indicate
the dependence on the marginal proportions:
(M) = C0 expB0 logA0M
A linear model for this vector of coecients, i.e., a LCMM, can then be denoted as
(M) = X (5)
for an appropriate design matrix X and a parameter vector . With the columns of U
spanning the orthogonal complement of the space spanned by the columns of X, we can give
the equivalent representation
U0(M) = 0 (6)
With n a vector of frequencies, the kernel of the multinomial log likelihood is given as
L(jn) = n0 log  N10 (7)
where N is the sample size. The problem now is to nd an estimator of  subject to the
constraint (6), or of  subject to (5), when the data vector n follows a multinomial likelihood.
Two dierent estimation procedures have been developed for models of this type and more
general models: the weighted least squares (WLS) method (Grizzle, Starmer, & Koch, 1969)
and the maximum likelihood (ML) method (Lang & Agresti, 1994; Bergsma, 1997; Lang,
2004; Bergsma et al., 2009).
WLS is based on the the asymptotic covariance matrix of the sample value of (M). Using
the delta method this leads to the WLS estimator
~ =

X0
 
JMDpM
0J0
 1
X
 1
X0
 
JMDpM
0J0
 1
JMp:
where J is the Jacobian of , p is the vector of observed probabilities, and Dp is the diagonal
matrix with p on the main diagonal (see also, e.g., Koch, Landis, Freeman, & Lehnen, 1977).
The ML method is computationally more complex and based on maximizing the multinomial
log likelihood (7) subject to the constraint (6). The constrained ML solution is a stationary
point of the Lagrangian expression
L(jn)  0U0(M)
where  is a vector of Lagrange multipliers. A scoring type algorithm which works well in
practice is given in Bergsma et al. (2009) (see also Bergsma, 1997). The algorithm assumes
the regularity conditions that U has full column rank and the Jacobian J has full row rank,
which are normally satised in practice.
8Once the estimates ^ have been obtained, marginal models can be tested by means of two
well-known test statistics: the likelihood ratio test statistic
G2 =  2N
X
i
pi log
^i
pi
and Pearson's chi-square test statistic
X2 = N
X
i
(pi   ^i)2
^i
:
If the postulated model is true, these test statistics have an asymptotic chi-square distribution
with degrees of freedom (df) equal to the number of independent constraints on the cell
probabilities. Assuming the aforementioned regularity conditions, df equals the row rank
of U.
Both ML and WLS share the same desirable asymptotic properties. The advantage of WLS
is the ease of computation, in particular, closed form expressions for the estimators exist.
However, the WLS method is very sensitive to sparseness in the data, while the ML method
can be used for much smaller data sets (see Berkson, 1980, and the discussion of that paper).
An alternative method is Generalized Estimating Equations (GEE) (Liang & Zeger, 1986).
Here, unlike for the ML method, a predened correlation structure has to be assumed, which
may be arbitrary. For more details about this method, the reader is referred to Skrondal and
Rabe-Hesketh (2004, Section 6.9), Molenberghs and Verbeke (2005), or Bergsma et al. (2009,
Section 7.2.1).
3.4 Application to the Case Study
The models described in previous section were applied to the data from our case study.
Results of several dierent LCMMs for pain, redness and irritability are presented in Table 4.
For all three symptoms, the no dierence model t the data poorly, indicating that there
could be a dierence between groups, either constant across all 4 days or not.
For redness (resp. irritability), the hypothesis of a constant dierence is acceptable as the
estimated values from the constant dierence model are not statistically signicantly dierent
from the observed ones (p = 0:849 and p = 0:344, respectively). The estimated value for the
dierence overall per day is 5.60% (resp. 4.21%) and it is statistically signicant (p = 0:001
and p = 0:022, respectively).
For pain, even if the data does not show strong evidence that the dierences vary among time
(t of the constant dierence model is p = 0:106), we could consider to evaluate dierences
between group by day. Considering the varying dierence model, we see that the active
group has a statistically lower incidence of pain than the control group only for day 2 if not
controlled for multiplicity (p = 0:019, pB H = 0:076). For the other days, no statistically
signicant dierence was found. Hence, looking per day here, does not seems to bring much
additional information to the evaluation of the dierence between group. In addition, there
does not seem to be a strong evidence for an overall dierence between the groups (overall
eect p-value is p = 0:140).
Comparing the results produced here and the ones obtained by standard analysis techniques,
several remarks can be made. For pain, using the LCMM allows to see that although there
might be some variability of the dierence between groups across days, this variability is
rather small, and the overall dierence between the group also seems negligible. For redness,
using the LCMM provides similar information as we would have found considering dierences
9Table 4: Fit and eect estimates of dierent Linear Categorical Marginal Models with ML
Estimation for the solicited symptoms observed during the 4-day post vaccination period.
Expected dierence Model-based
Model Fit Control - Active p-value
Model Symptoms G2 df p-value Day Di se Unadjusted B-H
No dierence Pain 8.46 4 0.076 1, 2, 3 or 4 0 - - -
Redness 8.82 4 0.066 1, 2, 3 or 4 0 - - -
Irritability 11.46 4 0.022 1, 2, 3 or 4 0 - - -
Constant Pain 6.16 3 0.106 1, 2, 3 or 4 1.95 1.32 0.140 -
dierence Redness 0.84 3 0.849 1, 2, 3 or 4 5.60 1.74 0.001 -
Irritability 3.32 3 0.344 1, 2, 3 or 4 4.21 1.85 0.022 -
Varying Pain 0.00 0 1.000 1 -0.54 2.46 0.827 0.827
dierence - 2 6.11 2.61 0.019 0.076
- 3 4.13 2.17 0.057 0.171
- 4 2.43 1.51 0.106 0.212
Redness 0.00 0 1.000 1 4.41 2.55 0.083 0.083
- 2 6.84 2.55 0.007 0.021
- 3 6.39 2.57 0.013 0.026
- 4 5.96 2.14 0.005 0.020
Irritability 0.00 0 1.000 1 3.01 2.59 0.244 0.675
- 2 1.18 2.59 0.648 0.675
- 3 2.96 2.43 0.224 0.675
- 4 5.23 2.14 0.015 0.060
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overall: a statistically signicant dierence is found overall between the two groups, and this
dierence seems to be constant across time. Further this dierence is very close using the 2
approaches: 5.7% for the dierences and 5.6% for the LCMM. However, using the LCMM
allows us to show that this is a correct strategy to describe the result overall as the constant
dierence model ts the data well. For irritability, using the LCMM, a statistically signicant
dierence is found between the two groups (4.2%), and seems to be constant along time
between the two groups (Constant dierence model p = 0:344)). However, this dierence is
not really seen when considering the dierences overall per subject (0.7%), or within each
day independently except for day 4 where the dierence is statistically signicant even after
correction for multiplicity. In this case, it might make more sense to conclude that there is a
small but constant dierence between the two groups, rather than no dierence until day 3
and a dierence at day 4.
We also tted the same model using WLS and found little dierences in p-values obtained
compared to the ML procedure. For example, the only dierence, in terms of unadjusted
p-values, were for pain (p = 0:138 instead of 0.140 for the constant dierence model), and
irritability (p = 0:024 instead of 0.022 for the constant dierence model, and 0.225 instead
of 0.224 for the dierence on day 3 for the varying dierence model).
4 Use of Linear Categorical Marginal Models for the Analysis
of Several Intensities
In Section 3, we have tested for dierences between the two groups regarding the occurrence
of symptoms at a specic intensity. In this section, we extend this approach by formulating
models that take into account the full scale at which the intensities were measured, rather
than the simple dichotomy used in the previous section. We will treat the scale of intensity
as ordinal; subjects are considered to have answered three successive dichotomous questions:
were there any symptoms? were they least of moderate intensity? were they of severe inten-
sity? Thus, we treat the data as truly categorical rather than as a realization of an underlying
continuum (see Hagenaars, 2010, for an extensive discussion of the history and philosophy
of this approach). Therefore, in the present setup we not only have the dependencies over
time which we already encountered in Section 3, but also, at each time point, we have several
dependent dichotomous variables. Below, we show how marginal models can also be used to
handle these more complex dependence relations.
4.1 Modeling the dierence of multivariate marginal proportions
In Section 3 we have not taken the fact that symptoms were measured on a four point
scale into account, that is we only compared proportions of having no symptoms (S = 0)
versus having a symptom with a certain intensity (S = 1; 2; 3). To make use of the intensity
information, we can also look at the dierences in proportions of those who had S = 0; 1 vs.
S = 2; 3 and those who had S = 0; 1; 2 vs S = 3. Introduce the new variable R, which takes
the following values: R = 1 if S  1, R = 2 if S  2, and R = 3 if S = 3. Let
Rr
jG
g
T
t
be the proportion of respondents from group g given time t who experience the symptom with
an intensity of at most r. Then we can dene the two-way table of dierences in proportions
for active and control by
Tt
R
r = 
R
r
jG
1
T
t   Rr jG2 Tt
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The saturated model, which does not impose any restrictions, is denoted as
Tt
R
r = + 
T
t + 
R
r + 
T
t
R
r for all r and t
for some unknown  and  parameters. The  parameters can be identied by imposing
restrictions such as
P
t 
T
t = 0,
P
r 
R
r = 0, and
P
t 
T
t
R
r =
P
r 
T
t
R
r = 0.
The most parsimonious model is that all dierences are zero,
Tt
R
r = 0
We will refer to this model as the no dierence model. It has here twelve independent
restrictions on the probability distribution, so there are 12 degrees of freedom. The model
asserting constant dierences between active and control groups across time and intensities
is
Tt
R
r = 
We will refer to this model as the constant dierence model. It has 11 degrees of freedom.
The model asserting constant dierences between active and control groups for each level of
intensity R is
Tt
R
r = + 
R
r
We will refer to this model as the constant dierence model by intensity. It has 9 degrees
of freedom. The model asserting an independent eect of both time and intensity between
active and control groups is
Tt
R
r = + 
R
r + 
T
t
We will refer to this model as the independent intensity and time eect model. For this model,
the dierence between active and control group for each level of intensity R is dierent, but
the eect of time on this dierence is the same for all intensities. It has 6 degrees of freedom.
Here also, the likelihood ratio test statistic G2 and X2 have an asymptotic chi-square dis-
tribution if the postulated model is true, with degrees of freedom equal to the number of
independent constraints on the cell probabilities.
Several other models for modeling repeated ordered categorical variables have been developed
but will not be discussed here (see, e.g. Molenberghs & Verbeke, 2005).
4.2 Application to the Case Study
Considering results by day from Table 3, signicant dierences not taking into account mul-
tiplicity, are noted for pain at day 1 (for intensity higher than 2 or intensity 3), at day 2 (for
all 3 categories), for redness at days 2, 3 and 4 (for any intensity or intensity higher than 2),
and for irritability at day 4 (for any intensity or intensity higher than 2). However, when
correcting for multiplicity via the Bonferroni-Holm procedure, only 4 signicant dierences
are found: for pain at day 1 (for intensity higher than 2 or intensity 3), at day 2 (for intensity
higher than 2), and for redness at day 4 (for any intensity)
Analysis of this data by LCMMs may provide more insight in the data. Results of the t of
LCMMs taking into account the several intensities are shown in Table 5 (intensity 0 vs. 1, 2
and 3, or 0 and 1 vs. 2 and 3, or 0, 1 and 2 vs. 3 are simultaneously tested).
For irritability, as the no dierence model yields a good t to the data (p = 0:221), we
nd no evidence for a dierence between the 2 groups in terms of any intensity at any time
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Table 5: Fit of dierent marginal models of the solicited symptoms of several intensities
observed during the 4-day post vaccination period by either ML or WLS estimation procedures
Estimation No dierence Constant dierence Constant dierence Independent intensity
procedure Symptom model model model by intensity & time eect model
ML G2 df p-value G2 df p-value G2 df p-value G2 df p-value
Pain 33.8 12 <0.001 32.5 11 <0.001 29.9 9 <0.001 16.1 6 0.013
Redness 22.5 12 0.032 21.7 11 0.027 7.11 9 0.625 1.8 6 0.938
Irritability 15.3 12 0.221 15.4 11 0.166 10.75 9 0.293 7.6 6 0.269
WLS W 2 df p-value W 2 df p-value W 2 df p-value W 2 df p-value
Pain 27.6 12 0.006 27.5 11 0.004 26.4 9 0.002 15.4 6 0.017
Redness 22.7 12 0.031 20.2 11 0.043 7.34 9 0.602 1.7 6 0.941
Irritability 14.3 12 0.283 14.1 11 0.225 10.17 9 0.337 7.6 6 0.267
Table 6: Dierences between the groups and the dierent intensities for the solicited symptom
pain overall days post vaccination. Results of the constant dierence model by intensity
Control - Active
0 vs 1,2,3 0,1 vs 2,3 0,1,2 vs 3
Symptoms Day Di (%) p-value Di (%) p-value Di (%) p-value
Redness 1,2,3,4 4.93 0.003 2.18 0.009 -0.17 0.124
Pain 1,2,3,4 1.22 0.325 1.59 0.025 0.814 0.041
points. It can be observed that this result is not supported by the conclusions obtained in
Section 3.4, in which a signicant eect was found. This is may be attributed to the fact
that extra comparisons are taken into account here that may mask a specic eect, which
can also occur, e.g., when considering the eect of factors in ANOVA models.
For redness, the assumption of no dierence cannot be sustained (p = 0:032) and it seems
further that the dierence between the groups is not the same for all intensities (p = 0:027),
but when considering each intensity this dierence seems constant along time (p = 0:625). In
fact, it seems that for redness, the dierences between the groups is much more pronounced
for symptoms with low intensity than for symptoms with high intensity (see Table 6).
Contrary to the analyses of irritability or redness, the t of the dierent models shown in
Table 5 seems to indicate that the analysis of pain should be handled by intensity and time
point. The independent intensity and time model does not t the data very well either (p =
0:013) providing some evidence for an interaction between the two factors. From Table 3, we
see indeed that for the highest intensities, a dierence between the groups appears earlier and
disappears also earlier, than when considering any intensity. Hence, for pain, summarizing
the results across intensity and/or time may lead to substantial loss of information.
Using the LCMMs in this setting allows us to easily conrm that, there are no marked
dierences for irritability, that for redness dierences seems to occur rather constantly per
day for low to moderate intensity symptoms, and that for pain a more complex pattern has
to be taken into account to analyze the dierences as they are not only depending on the
intensities, but also on the days and on their interaction.
The results obtained with ML and WLS estimation procedures can be compared. Results
were similar when considering only one intensity comparison by solicited symptom, but are
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somewhat more dierent though the dierences remain quite small than when the intensity
was not taken into account (see Table 5). Here, all p-values are dierent with a maximal
dierence of 0.06 (p = 0:28 for WLS versus p = 0:22 for ML for the no dierence model for
irritability). This is probably due to larger and more sparse tables used when considering all
intensities at once. Dierent behaviors of the WLS and of the ML estimation procedure are
indeed likely to occur on sparse tables. Note that here the estimation problem of the WLS
procedure due to the sparseness of the table is more likely to happen, which makes the use
of the ML procedure more attractive here.
5 Simulation studies
We now compare the performance of the marginal modeling approach with two classical
approaches commonly used in clinical trials using a simulation study of 3 dierent types of
models with dierent correlation between the days. The data are simulated as follows. We
use n = 300 for both the control and the active groups and simulate from (i) the no dierence
model,
Tt = 0:00 for t = 1; : : : ; 4
(ii) the constant dierence model
Tt = 0:025 for t = 1; : : : ; 4
(iii) the constant dierence model
Tt = 0:05 for t = 1; : : : ; 4
(iv) the varying dierence model
T1 = 
T
2 = 0:05 
T
3 = 
T
4 = 0 (8)
(v) the varying dierence model
T1 = 
T
2 = 0:1 
T
3 = 
T
4 = 0 (9)
and (vi) the varying dierence model
T1 = 
T
2 = 0 
T
3 = 
T
4 = 0:05 : (10)
In all cases, we set the proportions experiencing a symptom for the control group equal to
0:65, 0:50, 0:25 and 0:15.
To simulate correlated data we need a model for the nuisance parameters as well. For this we
use two loglinear models. The rst is a naive model that the occurrence of symptoms at the
dierent time points are independent given treatment, denoted in loglinear model notation
as
fGS1; GS2; GS3; GS4g (11)
The second model adds conditional associations between symptom occurrence at the dierent
time points, and is denoted in loglinear model terms as
fGS1; GS2; GS3; GS4; S1S2; S2S3; S3S4g
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This model requires specication of an association parameter in marginal tables S1S2, S2S3,
and S3S4. We take a constant dierence in proportions,
S = 
St+1
1
jSt
1   St+11 jSt2 = 0:2
For the model (11), S = 0. For both approaches, and each case, 20,000 simulated samples
are produced.
For each simulated sample, the rst classical approach, called here the `any day' approach,
considers subjects who experienced the symptom at least once during any day of the follow
up, and tests dierences between groups using the Fisher's exact test. The second classical
approach entails computing the Fisher's exact p-value for the hypotheses H0t : 
T
t = 0 for
all t with the Bonferroni-Holm (B-H) correction. For the marginal modeling approach, the
strategy followed to detect an eect is similar to the one used in Section 3. First, the
constant dierence model is tested, the alternative being the varying dierence model which
is the saturated model. If the constant dierence model is not rejected (model t p-value
 0:05), then the constant dierence across all 4 days is tested for signicance. If the constant
dierence model is rejected, the varying dierence model is used and the estimated dierences
for each day are tested for signicance using the B-H correction. The overall probability of
obtaining signicant dierences between the groups by the marginal approach, denoted as
Pdi in the following, is thus obtained as the weighted average of the 2 types of dierence
tests previously estimated.
Table 7: Simulation results: Type I error and power of the dierent models (H1 being the
constant dierence model)
Classical LCMM
Model for approaches approach
Simulation nuisance `any day' B-H H1 accepted H1 rejected Overall
model for Tt
R
r parameters Pdi P(accept H1) Pdi Pdi Pdi
No dierence S = 0 0.032 0.038 0.948 0.050 0.314 0.063
(Tt = 0) 
S = :2 0.058 0.038 0.948 0.051 0.261 0.063
Constant di. S = 0 0.323 0.196 0.951 0.306 0.703 0.326
(Tt = 0:025) 
S = :2 0.535 0.304 0.947 0.401 0.765 0.420
Constant di. S = 0 0.831 0.587 0.948 0.837 0.948 0.844
(Tt = 0:05) 
S = :2 0.967 0.835 0.938 0.946 0.989 0.948
Varying di. S = 0 0.325 0.273 0.818 0.190 0.726 0.287
(Eq. (8)) S = :2 0.488 0.354 0.800 0.245 0.789 0.354
Varying di. S = 0 0.823 0.810 0.371 0.584 0.950 0.815
(Eq. (9)) S = :2 0.929 0.903 0.346 0.717 0.982 0.890
Varying di. S = 0 0.322 0.452 0.799 0.478 0.803 0.544
(Eq. (10)) S = :2 0.619 0.659 0.762 0.629 0.911 0.696
The simulation results are shown in Table 7. We rst see that the classical `any day' approach
can be either conservative or liberal according to the strength of the association between
the dierent days. Then we see that the classical B-H approach is slightly conservative,
with too small probabilities corresponding to the type I error, while the marginal modeling
approach using LCMMs as applied with the above strategy is slightly liberal. However,
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this shortcoming should not really penalize the marginal modeling approach in the context
of analyses of solicited and unsolicited symptoms as the priority is often put on detecting
dierences rather than conrming them. In this respect, the simulations show that the
marginal modeling approach is signicantly more powerful than the B-H approach when
simulations are done from the constant dierence models. For simulations done from the
varying dierence models the two approaches yield comparable power. Compared to the
`any day' approach, the marginal modeling approach yields similar or better results (data
corresponding to Equation (10)) in terms of power when there is no association between the
days. Whenever there is some association between the days, the `any day' approach can be
more powerful than the marginal modeling one for the constant dierence models, while for
the varying eect models, which model is the most powerful seems to depend on the structure
of the dierences.
In addition, the marginal modeling approach is more exible than the classical approaches,
as a wider range of hypotheses can be tested and corresponding parameter estimates can
be obtained. As shown in Table 7, using LCMMs the marginal modeling approach can also
help to nd the correct structure of the dierences. For example, in the varying dierence
simulated data corresponding to Equation (9), in more than 60% of the cases it can be
concluded that there is a signicant eect and that this eect diers among days, and in the
constant dierence simulated data Tt = 0:05 it can be concluded in more than 80% of the
cases that there is a signicant eect and that this eect is constant among days, and only
in less than 7% of the cases that there is a signicant eect diering among days.
6 Conclusions
Without making unnecessary assumptions, LCMMs have been shown to take into account
the dependencies that arise due to the repeated measurements of the solicited symptoms
experienced after vaccination. They allow a better understanding of the relative safety prole
of the several groups considered by testing correctly global hypotheses rather than looking at
a list of p-values. In addition, interpretation is easy, the eect parameters derived from these
models being expressed in terms of dierence of percentages. The use of this method has the
potential to improve the quality of global evaluation of the occurrence of solicited symptoms
especially when several intensities, observation days, and/or doses are considered. Further,
it is not limited to solicited symptoms and could also be applied to unsolicited symptoms,
or even non safety data, provided that the occurrence of the event of interest is suciently
frequent. Use of the ML estimation procedure will also bring some added value compared to
the WLS procedure especially for complex models.
However, use of the ML estimation method presented above will not be straightforward in a
clinical standard setting. Indeed, the estimation procedure, although available in an R pack-
age, is still not yet present in an ISO validated software. Furthermore, satisfactory strategies
for the handling of missing data have not been yet been developed for this procedure. Hence,
further developments in terms of handling missing data and accessibility of the method are
still needed to be able to be used by a broader audience. Current work of the authors of this
article is aimed at tackling these shortcomings.
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